相关实验视频

Updated: Jul 14, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

使用小分子调节器验证BV2微质细胞中的Hv₁通道功能

Ashutosh Sharma^1,2, Nandini B Kale³, Priyanka Yadav^1,2

¹Neuroscience and Ageing Biology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, India.

Frontiers in cellular neuroscience

|August 13, 2025

概括

微中的电压受控质子通道1 (Hv1) 调节大脑炎症. 抑制Hv1会减轻神经炎症,而激活它会使其恶化,影响从神经疾病到癌症的疾病.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

微质细胞是关键的大脑免疫细胞,在损伤和修复方面具有双重作用.
失调的微质激活有助于二次脑损伤.
电压关闭的质子通道 (Hv1) 在微质细胞中表达,并影响它们的激活状态.

研究的目的:

研究微质Hv1通道在神经炎症中的作用.
描述一种新型Hv1激活剂 (S-023-0515) 和一种抑制剂 (YHV98-4) 的作用.
为了验证Hv1作为炎症性大脑疾病的治疗点.

主要方法:

在BV2微质细胞中利用脂聚糖 (LPS) 诱导的神经炎症模型.
使用的HV1抑制剂YHV98-4和HV1激活剂S-023-0515.
评估了益炎性细胞因子 (TNF-α,IL-6,iNOS),微质极化,细胞和活性氧物种 (ROS) 的水平.
分析了NF-κB信号通路的参与.

主要成果:

在LPS刺激的微质中,YHV98-4治疗减少了促炎媒介.
S-023-0515增加了M1极化,促炎媒介,细胞化和线粒体ROS.
这两种化合物都调节了NF-κB酸化,表明该途径参与.
在这个模型中,HV1抑制显示出神经保护作用,而激活则是神经毒性.

结论:

Hv1通道在调节微质激活和炎症反应方面发挥着至关重要的作用.
对HV1的药理调节为控制神经炎症疾病提供了潜在的策略.
在神经炎症的背景下,HV1抑制是神经保护性的,而HV1激活是神经毒性的.

关键词:

在HV1频道.这就是ROSOS ROS.激活器激活器是什么抑制剂抑制剂的使用微质细胞中的微质细胞神经炎症是一种神经炎症.信号通道的信号通道.验证验证的时间

更多相关视频

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity

Published on: October 25, 2016

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

相关概念视频

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...